Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may lower cholesterol and slow heart disease progression.

Sunlight exposure damages hair follicles, but certain stem cell-derived particles can reduce this damage and help with hair regeneration.

A new ethical skin model using stem cells offers a reliable alternative for dermatological research.

Cells lacking the Bax protein can outcompete others, leading to better tissue repair and hair growth.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Substances from fat-derived stem cells can promote hair growth and counteract hormone-related hair loss by activating a key hair growth pathway.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Injecting a person's own fat stem cells into their skin can make it look younger and improve double eyelids for over a year.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

The reviewers found the manuscript on inflammation's role in cancer stem cells to be relevant but suggested it needs clarity, more background information, discussion on immune cells' role in tumors, updated references, and grammar corrections.

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

The reviewers suggest clarifying and expanding on the role of inflammation in stem cell-related cancer development.

The reviewers suggest major revisions for clarity and inclusion of recent findings on inflammation's role in cancer.

Reviewers suggest clarifying the abstract, adding background on inflammation's effect on cancer, discussing immune cell roles, including counter studies, and correcting grammar.

The revised study on how inflammation affects cancer stem cells was accepted after improving clarity and structure.

The revised manuscript on how inflammation affects cancer stem cells was accepted after addressing issues with clarity and detail.

Exosomes may improve skin, scars, hair growth, and fat grafts in plastic surgery, but more research is needed.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Hair transplantation can improve scars after removing a rare skin cancer.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Using one's own blood platelets and fat can improve facial and hair appearance without surgery.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.